GBCA dose drops significantly in breast MRI thanks to machine learning

synthetic contrast-enhanced breast MRI

MRI scans in a 55-year-old woman with right invasive ductal carcinoma (left panel) and a 67-year-old woman with right invasive ductal carcinoma (right panel) show failed enhancement of the index lesion (arrow) on the simulated (i.e., synthetic) contrast-enhanced MRI scans.

Image courtesy of Radiology.

The use of synthetic images could reduce the amount of gadolinium-based contrast agents needed for breast MRI examinations, according to new data published this week in Radiology